# Adoptive Cellular Therapy and Radiation Therapy After Surgery in Treating Patients With Esophageal Cancer

> **NCT01691664** · NA · UNKNOWN · sponsor: **Capital Medical University** · enrollment: 40 (estimated)

## Conditions studied

- Esophageal Cancer

## Interventions

- **RADIATION:** Only radiation therapy
- **OTHER:** Radiation therapy plus DC-CIK cellular therapy

## Key facts

- **NCT ID:** NCT01691664
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2021-12
- **Final completion:** 2022-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01691664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01691664, "Adoptive Cellular Therapy and Radiation Therapy After Surgery in Treating Patients With Esophageal Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01691664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*